Procurement Summary
Country: Brazil
Summary: Acquisition Veterinary Medicines I.
Deadline: 14 Nov 2025
Posting Date: 03 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 129395996
Document Ref. No.: 91101/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - PROCUREMENT OF VETERINARY MEDICINES I.
UASG code: 925003
Notice from: 03/11/2025 from 08:00 to 12:00 and from 13:00 to 17:59
Proposal Delivery: from 11/03/2025 at 08:00
AMOXICILLIN, CONCENTRATION 150 MG/ML, PHYSICAL FORM INJECTABLE ACTION EMULSION PROLONGED USE, VETERINARY USE
Quantity: 55
BENZYLPENICILLIN, COMPOSITION BENZATINE + PROCAINE + POTASSIUM, OTHER COMPONENTS DIHYDROESTREPTOMICIN + STREPTOMICIN, CONCENTRATION 3, 000, 000UI+1, 500, 000UI+1, 500, 000UI+1250MG+1250 MG, PHYSICAL FORM LYOPHIL POWDER FOR INJECTABLE, APPLICATION USE VETERINARY
Quantity :66
CYCLOSPORINE, CONCENTRATION 0.5 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC EMULSION
Quantity: 60
YOHIMBINE, CONCENTRATION 10 MG/ML, INJECTABLE PHARMACEUTICAL FORM, VETERINARY USE APPLICATION
Quantity: 25
DOXAPRAM HYCLORIDATE, CONCENTRATION 20 MG/ML, PHYSICAL FORM INJECTABLE SOLUTION, VETERINARY USE
Quantity :9
DOXYCYCLINE, CONCENTRATION 300 MG, PHYSICAL FORM POWDER FOR ORAL SUSPENSION FOR 60ML, VETERINARY USE
Quantity: 132
ENROFLOXACIN, CONCENTRATION* 50MG, PHYSICAL FORM PALATABLE TABLET, VETERINARY USE
Quantity: 1140
SPIRAMYCIN, COMPOSITION ASSOCIATED WITH METRONIDAZOLE, CONCENTRATION 750, 000 U_+ 125 MG, VETERINARY USE
Quantity: 1680
SPIRAMYCIN, COMPOSITION ASSOCIATED WITH METRONIDAZOLE, CONCENTRATION 750, 000 U_+ 125 MG, VETERINARY USE
Quantity: 1560
ITRACONAZOLE, CONCENTRATION 25 MG, VETERINARY USE APPLICATION
Quantity: 960
NEOMICIN, CONCENTRATION 5 MG/G, PHARMACEUTICAL FORM OINTMENT
Quantity: 72
OXITETRACYCLINE, 20% CONCENTRATION, PHYSICAL FORM INJECTABLE SOLUTION, USE* VETERINARY USE
Quantity: 9
TOPICAL HEMOSTATIC, ACTIVE INGREDIENT FERRIC SULFATE, LIQUID PHYSICAL ASPECT
Quantity: 27
SULFUR, COMPOSITION IN MINERAL OIL, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORMSUSPENSION OILY, ADDITIONAL CHARACTERISTICS SPECIALLY FORMULATION...
Documents
Tender Notice